Contribute Try STAT+ Today

WASHINGTON — The trade group for the pharmaceutical industry on Friday sued to block a  new process, outlined by the Trump administration, that aimed to help drug makers and health care providers resolve disputes over a federal drug discount program.

The suit is the latest in a flurry of recent legal actions between the Department of Health and Human Services, providers, and the pharmaceutical industry, after several drug makers aggressively cut back on the pharmacies they would allow to dispense discounted drugs through the 340B program last summer.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • If I could have read the whole story yes I would absolutely subscribe for my company.and how are you gonna advertise part of a very important story.I am angry because Google put ur ad on an. it was infuryating and very disappointing on only reading half a story and pay 365.00 wow during this pandemic that’s real sorry…so sorryyou lost my account.Good day

Comments are closed.